4//SEC Filing
GOLD DANIEL P PHD 4
Accession 0001209191-19-051197
CIK 0001262104other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 12:04 PM ET
Size
6.9 KB
Accession
0001209191-19-051197
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2019-09-27$1.57/sh+20,000$31,400→ 342,882 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-09-27−20,000→ 287,500 totalExercise: $1.57Exp: 2025-07-28→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]All of the options are fully vested and currently exercisable.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001288233
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 12:04 PM ET
- Size
- 6.9 KB